Skip to main content

Our Funds
Sower Solas I LP Fund

The Sower Solas I LP Fund is a timely investment opportunity focusing on life science innovations; innovations that fuel 20% of the US GDP​. In this fund, Sower has teamed up with Solas BioVentures, who has been investing in life science venture companies for decades.

The Sower Solas I LP Fund provides access to the Solas BioVentures Emerging Healthcare Fund​, a Fund with a total offering up to $100M.

Focus Areas





Solas Bioventures Thesis

Solas BioVentures prioritizes products or services with significant patient outcome impacts that offer asymmetric return profiles favoring investors.

Solas’ principals possess diverse skill sets including science investors, operators, clinicians and academic researchers.

Their experience fosters leading-edge approaches to life science investing, which has funded investor-friendly medical innovations. 

Solas’ principals and partners have experience in medical technology that is improving diagnosis, doctor-patient interactions, and treatment efficacy through the use of regulated medical technology.

BioTech Investing

Med-Tech has been in a devalued status representing ideal investment timeliness.

Venture Capital Investing

Most investor-friendly environment of the last decade.

Interested in Learning more about our investments?

Complete the form and a member of our investment team will be in touch.